RGEBX | SBHAX | RGEBX / SBHAX | |
Total Expense Ratio | 1.09 | 0.84 | 130% |
Annual Report Gross Expense Ratio | 1.09 | 0.93 | 117% |
Fund Existence | 11 years | 12 years | - |
Gain YTD | 4.829 | -0.410 | -1,179% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 306B | 92.1M | 332,248% |
Annual Yield % from dividends | 0.00 | 0.22 | - |
Returns for 1 year | 7.68 | -11.25 | -68% |
Returns for 3 years | 51.01 | 3.55 | 1,436% |
Returns for 5 years | 45.42 | 16.67 | 272% |
Returns for 10 years | 65.87 | 60.02 | 110% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GOVT | 22.70 | -0.07 | -0.31% |
iShares US Treasury Bond ETF | |||
BUFD | 25.96 | -0.17 | -0.65% |
FT Vest Laddered Deep Buffer ETF | |||
CIK | 2.86 | -0.03 | -1.04% |
Credit Suisse Asset Management Income Fund | |||
GNOM | 8.30 | -0.13 | -1.51% |
Global X Genomics & Biotechnology ETF | |||
LRGE | 76.21 | -1.25 | -1.62% |
ClearBridge Large Cap Growth ESG ETF |